Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation

被引:29
作者
Anderlini, P [1 ]
Sheth, S [1 ]
Hicks, K [1 ]
Ippoliti, C [1 ]
Giralt, S [1 ]
Champlin, RE [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
关键词
D O I
10.1016/j.bbmt.2004.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:883 / 884
页数:2
相关论文
共 6 条
[1]  
[Anonymous], COMMON TERMINOLOGY C
[2]  
BARRETT AJ, 1992, BLOOD, V79, P3067
[3]   Practical management of patients with chronic myeloid leukemia receiving imatinib [J].
Deininger, MWN ;
O'Brien, SG ;
Ford, JM ;
Druker, BJ .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1637-1647
[4]  
GRATWOHL A, 1993, BONE MARROW TRANSPL, V12, P509
[5]  
Guglielmi C, 2000, BLOOD, V95, P3328
[6]   Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation [J].
Olavarria, E ;
Craddock, C ;
Dazzi, F ;
Marin, D ;
Marktel, S ;
Apperley, JF ;
Goldman, JM .
BLOOD, 2002, 99 (10) :3861-3862